273 related articles for article (PubMed ID: 23039216)
1. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia.
Bramlage P; Gitt AK; Binz C; Krekler M; Deeg E; Tschöpe D
Cardiovasc Diabetol; 2012 Oct; 11():122. PubMed ID: 23039216
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry.
Gitt AK; Bramlage P; Binz C; Krekler M; Plate T; Deeg E; Tschöpe D;
Eur J Prev Cardiol; 2012 Aug; 19(4):765-72. PubMed ID: 21628353
[TBL] [Abstract][Full Text] [Related]
3. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
Kostev K; Dippel FW; Rathmann W
Prim Care Diabetes; 2014 Jul; 8(2):127-31. PubMed ID: 24183472
[TBL] [Abstract][Full Text] [Related]
4. Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.
Bramlage P; Gitt AK; Schneider S; Deeg E; Tschöpe D;
BMC Cardiovasc Disord; 2014 Nov; 14():162. PubMed ID: 25410473
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.
Kovatchev B; Umpierrez G; DiGenio A; Zhou R; Inzucchi SE
J Diabetes Sci Technol; 2015 Jun; 9(6):1227-35. PubMed ID: 26078255
[TBL] [Abstract][Full Text] [Related]
6. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
Seufert J; Pegelow K; Bramlage P
Vasc Health Risk Manag; 2013; 9():711-7. PubMed ID: 24259985
[TBL] [Abstract][Full Text] [Related]
8. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
9. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia.
Thorpe CT; Gellad WF; Good CB; Zhang S; Zhao X; Mor M; Fine MJ
Diabetes Care; 2015 Apr; 38(4):588-95. PubMed ID: 25592195
[TBL] [Abstract][Full Text] [Related]
10. New risk and protective factors for severe hypoglycaemia in people with type 1 diabetes.
Wohland T; Holstein JD; Patzer OM; Mende M; Tiemann T; Koch-Tessarek C; Kovacs P; Holstein A
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):407-414. PubMed ID: 28216284
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia in People with Type 2 Diabetes and CKD.
Ahmad I; Zelnick LR; Batacchi Z; Robinson N; Dighe A; Manski-Nankervis JE; Furler J; O'Neal DN; Little R; Trence D; Hirsch IB; Bansal N; de Boer IH
Clin J Am Soc Nephrol; 2019 Jun; 14(6):844-853. PubMed ID: 30996047
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
[TBL] [Abstract][Full Text] [Related]
13. Usage pattern, glycemic improvement, hypoglycemia, and body mass index changes with sulfonylureas in real-life clinical practice: results from OBSTACLE Hypoglycemia Study.
Kalra S; Deepak MC; Narang P; Singh V; Uvaraj MG; Agrawal N
Diabetes Technol Ther; 2013 Feb; 15(2):129-35. PubMed ID: 23289432
[TBL] [Abstract][Full Text] [Related]
14. Predictors of early discontinuation of basal insulin therapy in type 2 diabetes in primary care.
Kostev K; Dippel FW; Rathmann W
Prim Care Diabetes; 2016 Apr; 10(2):142-7. PubMed ID: 26324105
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
[TBL] [Abstract][Full Text] [Related]
16. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry.
Prinz N; Stingl J; Dapp A; Denkinger MD; Fasching P; Jehle PM; Merger S; Mühldorfer S; Pieper U; Schuler A; Zeyfang A; Holl RW;
Diabetes Res Clin Pract; 2016 Feb; 112():73-81. PubMed ID: 26563590
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
Bae JP; Duan R; Fu H; Hoogwerf BJ
Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
[TBL] [Abstract][Full Text] [Related]
18. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
19. Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents.
Abe H; Shikuma J; Suwanai H; Sano K; Okumura T; Kan K; Takahashi T; Miwa T; Suzuki R; Odawara M
Geriatr Gerontol Int; 2019 Oct; 19(10):1030-1035. PubMed ID: 31486247
[TBL] [Abstract][Full Text] [Related]
20. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
